Clinical Trials Directory

Trials / Unknown

UnknownNCT03872648

TransCare - Genital Surgery for Trans Women in Centralized vs. Decentralized Health Care Delivery Settings

Status
Unknown
Phase
Study type
Observational
Enrollment
64 (estimated)
Sponsor
Universitätsklinikum Hamburg-Eppendorf · Academic / Other
Sex
Male
Age
16 Years
Healthy volunteers
Not accepted

Summary

Trans (i.e., transgender, transsexual) individuals experience a gender that does not match their sex assigned at birth (Gender Incongruence), which can lead to distress called gender dysphoria (formerly known as transsexualism). Trans health care (THC) is primarily focusing on transition-related medical interventions (e.g. genital surgery) to reduce gender dysphoria and improve the quality of life. To date, trans individuals access THC services in both decentralized (e.g., various transition-related interventions are spread over several locations) and centralized structures (e.g., gender affirmative medical treatments are provided by a single source). The TransCare study examines genital surgery for trans women (e.g. penile inversion vaginoplasty), focusing on the effect of different health care delivery settings (e.g., if patients received all treatments from a single source or spread over several locations) on psychosocial outcomes and the quality of healthcare.

Conditions

Timeline

Start date
2019-01-21
Primary completion
2021-06-01
Completion
2021-12-01
First posted
2019-03-13
Last updated
2019-11-07

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT03872648. Inclusion in this directory is not an endorsement.